VeriMomsr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) est-il sûr pendant la grossesse ?
No harmonised CLP classification, SCCS or CIR reproductive safety assessments, or peer‑reviewed reproductive/toxicity studies identified for the named peptides. These are peptide/protein actives (high molecular weight, proteolytically degradable) with expected minimal dermal systemic bioavailability when used topically, and no evidence of teratogenicity or endocrine activity was found in available sources (ECHA Annex VI; PubMed; CosIng; PubChem).
Related ingredients
Frequently asked questions
- sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) est-il sûr pendant la grossesse ?
- No harmonised CLP classification, SCCS or CIR reproductive safety assessments, or peer‑reviewed reproductive/toxicity studies identified for the named peptides. These are peptide/protein actives (high molecular weight, proteolytically degradable) with expected minimal dermal systemic bioavailability when used topically, and no evidence of teratogenicity or endocrine activity was found in available sources (ECHA Annex VI; PubMed; CosIng; PubChem).
- sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) est-il sûr pendant l'allaitement ?
- No data indicating reproductive or lactation hazard, no harmonised classifications, and no mechanistic evidence for transfer into breast milk. Topically applied peptides are expected to be degraded and have negligible systemic exposure; no studies suggest transfer to breast milk or effects on nursing infants (sources searched: ECHA Annex VI, PubMed, CosIng, PubChem).
- sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) est-il sûr pour la peau de bébé ?
- No toxicity or developmental data specific to infants found. Adult hazard/mechanism assessments are absent. Although dermal absorption of intact peptides is expected to be very low, infant (0–3 yr) skin has higher surface-area-to-weight and immature barrier function, so exposure score is increased by +1 to reflect potentially higher but still likely low absorption; no evidence of infant-specific adverse effects was identified (sources: PubMed, CosIng, ECHA Annex VI, PubChem).
- Comment VeriMom évalue-t-il sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) ?
- VeriMom évalue sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.